ACLX – arcellx, inc. (US:NASDAQ)
Stock Stats
News
Arcellx (NASDAQ:ACLX) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Arcellx to Advance the Conversation on Its Platform and the Importance of Early CAR T Access for Patients with Multiple Myeloma During the 2026 Tandem Meetings [Yahoo! Finance]
Arcellx to Advance the Conversation on Its Platform and the Importance of Early CAR T Access for Patients with Multiple Myeloma During the 2026 Tandem Meetings
Arcellx (NASDAQ:ACLX) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
Arcellx (NASDAQ:ACLX) was given a new $100.00 price target on by analysts at UBS Group AG.
Form 4 Arcellx, Inc. For: Jan 20 Filed by: Lubner David Charles
Form 144 Arcellx, Inc. Filed by: Lubner David Charles
Form 144 Arcellx, Inc. Filed by: Heery Christopher
Form 4 Arcellx, Inc. For: Jan 14 Filed by: Heery Christopher
Form 144 Arcellx, Inc. Filed by: Heery Christopher
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.